1. Home
2. BVIKM-SBIMC symposia
3. Symposia
4. 44th symposium

44th symposium

STATE OF THE ART ON THE PK/PD OF GLYCOPEPTIDES

• Presentation of the PK/PD workgroup. [Isabel SPRIET (UZ Leuven, Leuven)]
• Spectrum of vancomycin and susceptibility testing. [Olivier DENIS (Hôpital Erasme - ULB, Brussels)]
• Clinical use of glycopeptides. [Herbert SPAPEN (UZ Brussel, Brussels)]
• Latest issues in the PK/PD of vancomycin. [Stefaan VANDECASTEELE (AZ Sint-Jan, Bruges)]
• Therapeutic drug monitoring: news from the lab. [Pieter VERMEERSCH (UZ Leuven, Leuven)]
• Vancomycin use in special populations. [Maya HITES (Hôpital Erasme - ULB, Brussels)]
• Pro and con debate: vanvomycin versus linezolid. [Dirk VOGELAERS (UZ Gent, Gent) en Frédéric FRIPPIAT (CHU Liège, Liège)]